"/> Novus Biologicals™ Peptide bloquant d’anticorps BC… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps BCL9-2

Réf. : BL-RE-104765Réf. fabricant : 18287625 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
283149
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76542. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 20 amino acid peptide near the amino terminus of human Bcl9L.

Points forts

Source

Synthetic

(Accession #: NP_872363) The BCL9-2 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-104765
Réf. fabricant18287625
Gene ID (Entrez)283149
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76542. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneB-cell CLL/lymphoma 9-like, B-cell CLL/lymphoma 9-like protein, B-cell lymphoma 9-like protein, BCL9-like protein, DLNB11BCL9-2, nuclear co-factor of beta-catenin signalling, Protein BCL9-2
Symbole de gène(s)BCL9L
Type de produitBCL9-2
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne20 amino acid peptide near the amino terminus of human Bcl9L
Une question, une configuration particulière ?
Contactez-nous pour un devis.